- Report
- January 2024
- 150 Pages
Global
From €4552EUR$4,850USD£3,824GBP
- Report
- July 2024
- 100 Pages
Global
From €3520EUR$3,750USD£2,956GBP
- Report
- August 2024
- 170 Pages
Global
From €2346EUR$2,500USD£1,971GBP
- Report
- March 2024
- 163 Pages
Global
From €2346EUR$2,500USD£1,971GBP
- Report
- November 2023
- 29 Pages
United States
€2346EUR$2,500USD£1,971GBP
- Report
- May 2024
- 400 Pages
Global
From €3750EUR$3,995USD£3,150GBP
- Report
- February 2024
- 202 Pages
Global
From €4693EUR$5,000USD£3,942GBP
- Report
- February 2024
- 175 Pages
Global
From €4693EUR$5,000USD£3,942GBP
- Report
- February 2024
- 200 Pages
Global
From €4693EUR$5,000USD£3,942GBP
- Report
- January 2024
- 175 Pages
Global
From €4693EUR$5,000USD£3,942GBP
- Report
- January 2024
- 185 Pages
Global
From €4599EUR$4,900USD£3,863GBP
- Report
- February 2024
- 300 Pages
Global
From €2346EUR$2,500USD£1,971GBP
- Report
- January 2024
- 292 Pages
United States
From €3332EUR$3,550USD£2,799GBP
- Report
- February 2024
- 100 Pages
Africa
From €1877EUR$2,000USD£1,577GBP
- Report
- May 2024
- 300 Pages
Global
From €3750EUR$3,995USD£3,150GBP
- Report
- August 2024
- 381 Pages
Global
From €4504EUR$4,799USD£3,783GBP
- Report
- December 2023
- 110 Pages
Global
From €4504EUR$4,799USD£3,783GBP
- Report
- September 2024
- 343 Pages
Global
From €4504EUR$4,799USD£3,783GBP
- Report
- November 2023
- 124 Pages
Global
From €4224EUR$4,500USD£3,548GBP
- Drug Pipelines
- June 2024
- 160 Pages
Global
From €2816EUR$3,000USD£2,365GBP
The Vaccines market is a sector of the pharmaceutical industry that focuses on the development, production, and distribution of vaccines. Vaccines are used to prevent and treat infectious diseases, and are an important part of public health initiatives. Vaccines are typically developed by pharmaceutical companies, and then approved by regulatory bodies such as the US Food and Drug Administration (FDA).
The Vaccines market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies are involved in the development, production, and distribution of a wide range of vaccines, including those for influenza, measles, mumps, rubella, and hepatitis. Smaller companies are also involved in the Vaccines market, such as Emergent BioSolutions and Bavarian Nordic. Show Less Read more